Lead: Human brain effects of DMT assessed via EEG-fMRI

Lead: Human brain effects of DMT assessed via EEG-fMRI

Ever wondered how psychedelics like DMT affect your brain? This episode of 'This Week in Addiction Medicine' from ASAM dives into the fascinating world of N,N-Dimethyltryptamine (DMT) and its potential as a treatment for depression. Using advanced techniques like electroencephalography (EEG) and functional MRI (fMRI), researchers have uncovered some intriguing findings. They discovered that DMT causes a dysregulation in the transmodal association pole (TOP), an area rich in serotonin 2A receptors.

This dysregulation leads to increased communication between the TOP and other brain regions, potentially enhancing information processing and hyperassociative cognition. Imagine your brain working in overdrive, making connections faster than ever before. This episode doesn't just stop at psychedelics. It also explores a prospective study on patients with co-occurring psychiatric disorders receiving inpatient treatment for substance use disorder. Public attitudes towards opioid use and the link between social impairment and substance use are also discussed.

Additionally, you'll hear about a randomized clinical trial from China where personalized text messages based on behavior change theory doubled the quit rate for smokers compared to non-personalized messages. Finally, the episode delves into the potential of prescription psychostimulants as a treatment for cocaine use disorder. While the data is still emerging, there's hope that these stimulants could improve patient retention and outcomes when used as part of a comprehensive treatment plan.

Whether you're a healthcare professional, a student, or someone affected by addiction, this episode offers valuable insights into the latest research and treatments in addiction medicine.